Peripheral neuropathy decisions — 2025

The Board denied service connection for monoclonal gammopathy of uncertain significance, hypertension, and peripheral neuropathy in all extremities as there was no evidence to support the Veteran's claims of exposure to herbicide agents or other relevant factors.

The appeal for initial ratings in excess of 10 percent for bilateral lower extremity neuropathy associated with herbicide exposure was dismissed due to a procedural defect involving concurrent elections.

The Board granted an effective date of February 8, 2021, but not earlier, for the grant of service connection for left and right upper extremity peripheral neuropathy.

The Board denied the veteran's claims for increased ratings and service connection, as well as remanded several issues for further development.

The Board denied an increased rating for tinnitus and granted higher ratings for the low back disability, right and left lower extremity sciatic radiculopathy.

The Board granted service connection for peripheral neuropathy in all four extremities, finding a relationship to the Veteran's in-service herbicide exposure.

The Board remands the claims for service connection for a heart condition, prostate condition, and bilateral lower extremity peripheral neuropathy due to an inadequate VA examination.

The Board remands the claims for further development, including obtaining private medical records relevant to the Veteran's claims.

The Board denied an increased rating for right knee strain and left lower extremity peripheral neuropathy, but granted a separate initial 10 percent disability rating for symptomatic removal of the right knee semilunar cartilage.

The Board remands all service connection issues and entitlement to a total disability rating based on individual unemployability (TDIU) for further development.

The Board granted eligibility for the direct payment of attorney fees from past due benefits awarded in a May 2023 rating decision granting service connection for tinnitus, GERD and bilateral lower extremity neuropathy.

The Veteran withdrew the appeal for all claims, including those related to service-connected hearing loss, diabetes mellitus, and diabetic peripheral neuropathy.

The Board remands the claim for service connection for neuropathy of the right foot to obtain an adequate examination and opinion, as the previous VA examination was found inadequate.

The Board granted service connection for cervical spine degenerative arthritis and DDD, as well as radiculopathy of both upper extremities and diabetic peripheral neuropathy in both upper extremities. However, the claim for benign prostatic hypertrophy (BPH) was denied.

The Board granted earlier effective dates for the award of service connection for diabetes, CAD, and bilateral lower extremity diabetic peripheral neuropathy.

The Board denied the veteran's claims for increased ratings and a separate rating for left knee instability, as the evidence did not support higher ratings or additional benefits.

The appeal for revision of the October 2014 denial of service connection for obstructive sleep apnea based on clear and unmistakable error (CUE) was denied, as well as claims for earlier effective dates for grants of service connection for various conditions.

The Board granted service connection for vestibular migraines and residuals of basal cell carcinomas, and assigned a 60 percent rating from February 23, 2024, for the left lower extremity peripheral neuropathy.

The Board granted service connection for left and right foot peripheral neuropathy, both directly related to in-service cold injuries sustained during the Veteran's service in Korea.

The Board denied the Veteran's appeal for a higher rating for tinnitus, as it is already rated at 10 percent, which is the maximum allowed. The other issues are remanded for further development.